These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 32081494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis.
    Eckman MH, Woodle ES, Thakar CV, Paterno F, Sherman KE.
    Ann Intern Med; 2018 Aug 21; 169(4):214-223. PubMed ID: 29987322
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatitis C Virus Positivity Should Not Be Included in the Kidney Donor Profile Index Calculation When Transplanting HCV-Positive Kidneys Into Noninfected Recipients in the Era of Direct-Acting Antiviral Agents.
    Graham JA, Ajaimy M, Carrero J, Jones T, Torabi J, Alani O, Akalin E, Rocca JP.
    Prog Transplant; 2019 Dec 21; 29(4):371-372. PubMed ID: 31533529
    [No Abstract] [Full Text] [Related]

  • 7. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
    Bhamidimarri KR, Ladino M, Pedraza F, Guerra G, Mattiazzi A, Chen L, Ciancio G, Kupin W, Martin P, Burke G, Roth D.
    Transpl Int; 2017 Sep 21; 30(9):865-873. PubMed ID: 28332729
    [Abstract] [Full Text] [Related]

  • 8. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.
    Bethea ED, Gaj K, Gustafson JL, Axtell A, Lebeis T, Schoenike M, Turvey K, Coglianese E, Thomas S, Newton-Cheh C, Ibrahim N, Carlson W, Ho JE, Shah R, Nayor M, Gift T, Shao S, Dugal A, Markmann J, Elias N, Yeh H, Andersson K, Pratt D, Bhan I, Safa K, Fishman J, Kotton C, Myoung P, Villavicencio MA, D'Alessandro D, Chung RT, Lewis GD.
    Lancet Gastroenterol Hepatol; 2019 Oct 21; 4(10):771-780. PubMed ID: 31353243
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of HCV+ Donors Does Not Affect HCV Clearance With Directly Acting Antiviral Therapy But Shortens the Wait Time to Kidney Transplantation.
    Sawinski D, Patel N, Appolo B, Bloom R.
    Transplantation; 2017 May 21; 101(5):968-973. PubMed ID: 27495759
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of Kidneys Transplanted From Hepatitis C Viremic Donors to Naive Recipients From an Appalachian Rural Kidney Transplant Program.
    Gillis B, Villanueva D, Marsh W, Afridi F, Danforth J, Thornberg M, Chaudhary V, Sharma R.
    Exp Clin Transplant; 2024 Mar 21; 22(3):185-188. PubMed ID: 38695587
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors.
    Reyentovich A, Gidea CG, Smith D, Lonze B, Kon Z, Fargnoli A, Pavone J, Rao S, Saraon T, Lewis T, Qian Y, Jacobson I, Moazami N.
    Clin Transplant; 2020 Sep 21; 34(9):e13989. PubMed ID: 32441413
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness and system-wide impact of using Hepatitis C-viremic donors for heart transplant.
    Wayda B, Sandhu AT, Parizo J, Teuteberg JJ, Khush KK.
    J Heart Lung Transplant; 2022 Jan 21; 41(1):37-47. PubMed ID: 34635381
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ, Azhar A, Tsujita M, Talwar M, Balaraman V, Bhalla A, Podila PSB, Kothadia J, Agbim UA, Maliakkal B, Satapathy SK, Kovesdy CP, Nair S, Eason JD.
    Am J Kidney Dis; 2021 May 21; 77(5):739-747.e1. PubMed ID: 33333148
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C Virus Infection in ESKD Patients.
    Ladino M, Roth D.
    Clin J Am Soc Nephrol; 2018 Nov 07; 13(11):1735-1737. PubMed ID: 30065068
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.